Skip to main content
Watch Insiders
PACBHealthcare

Pacific Biosciences of California Inc (PACB) Insider Trading

In the last 90 days, 2 Pacific Biosciences of California Inc (PACB) insiders reported no open-market purchases and 2 sales totaling $2,087,330. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 6, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 6, 2026James R Gibson IISee RemarksSale661,815$3.11$2,056,921
Aug 17, 2026Oene Mark VanSee RemarksSale26,911$1.13$30,409

Common questions

PACB insider trading FAQ

Are PACB insiders buying or selling?
Over the last 90 days, PACB insiders were net sellers, reporting $0.00 of open-market purchases and $2,087,330 of sales.
When was the last PACB insider purchase?
No open-market insider purchase of Pacific Biosciences of California Inc stock was reported in the last 90 days.
Where does PACB insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Pacific Biosciences of California Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.